Holen Sie sich die Stockscreener-App
8.97
1.93%
0.17
Handel nachbörslich:
8.97
Schlusskurs vom Vortag:
$8.80
Offen:
$8.79
24-Stunden-Volumen:
8.21M
Relative Volume:
3.03
Marktkapitalisierung:
$1.05B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-9.5426
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-4.68%
1M Leistung:
-19.77%
6M Leistung:
-10.03%
1J Leistung:
-65.83%
1-Tages-Spanne:
$8.75
$9.505
1-Wochen-Bereich:
$8.26
$9.8116
52-Wochen-Spanne:
$7.06
$33.48
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
8.97 | 1.02B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know - ca.finance.yahoo.com
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience - Investing.com India
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience By Investing.com - Investing.com Australia
Shareholder Rights Advocates at Levi & Korsinsky Investigate Evolent Health, Inc. (EVH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Evolent Health at Canaccord Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Evolent Health’s Earnings Call: Balancing Growth and Challenges - MSN
Is This the Dip to Buy in Evolent Health Inc.Weekly Stock Recap & Low Volatility Stock Recommendations - 선데이타임즈
Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Call Transcript - Insider Monkey
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance
EVH ACTIVE INVESTIGATION: Contact Levi & Korsinsky If You Lost Money On Your Evolent Health, Inc. investment - ACCESS Newswire
Candlestick Reversal Detected on Evolent Health Inc.’s ChartFast Gaining Stock Screener Reports Released - beatles.ru
EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue - Yahoo Finance
Evolent Health, Inc. SEC 10-Q Report - TradingView
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
Further Weakness as Evolent Health (NYSE:EVH) Drops 9.8% This Week, Taking Three-year Losses to 74% - 富途牛牛
Evolent Health (EVH) Bolsters Management Team - MSN
How volatile is Evolent Health Inc. stockCapital Doubling Stock Strategy - mustnews.co.kr
Evolent Health's Strategic Position in the Evolving Managed Care Landscape - AInvest
Evolent Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:EVH) - Seeking Alpha
Should Evolent Health's (EVH) Declining Sales and Rising Losses Prompt Investor Reassessment of 2025 Outlook? - simplywall.st
Protect Your Investment: Contact Levi & Korsinsky About the Evolent Health, Inc. (EVH) Investigation - TradingView
Evolent Health (EVH) Stock Falls 13.9% on Disappointing Q2 ResultsNews and Statistics - IndexBox
Why Evolent Health (EVH) Stock Is Nosediving - Yahoo Finance
Earnings call transcript: Evolent Health’s Q2 2025 results miss forecasts - Investing.com
Evolent Health Q2 2025 slides reveal revenue drop amid rising debt leverage - Investing.com Canada
Evolent Health Q3 Revenue Guidance Lowered to $460M-$480M, EBITDA Sees $34M-$42M Range - AInvest
Evolent Health (NYSE:EVH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops - Yahoo Finance
Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... - Yahoo Finance
Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... By GuruFocus - Investing.com Canada
Evolent Health Reports Q2 2025 Earnings and Growth Outlook - TipRanks
Evolent Health's Q2 2025 Earnings and Strategic Turnaround: A Sustainable Recovery or a Temporary Bounce? - AInvest
Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Evolent Announces Second Quarter 2025 Results - The Malaysian Reserve
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Evolent Health: Q2 Earnings Snapshot - San Antonio Express-News
Evolent Health shares tumble 11% as Q2 results miss expectations - Investing.com India
Evolent Health Inc Reports Q2 2025 Earnings: EPS Loss of $0.44 M - GuruFocus
Evolent Health Inc earnings missed by $0.18, revenue fell short of estimates - Investing.com Australia
Earnings Flash (EVH) Evolent Health, Inc. Reports Q2 Revenue $444.3M, vs. FactSet Est of $459.6M - MarketScreener
(EVH) Evolent Health, Inc. Expects Q3 Revenue Range $460.0M$480.0M - MarketScreener
Earnings Flash (EVH) Evolent Health, Inc. Posts Q2 Adjusted Loss $0.10 per Share, vs. FactSet Est of $0.07 - MarketScreener
Evolent Health Quarterly Results: Financial Insights and Market TrendsNews and Statistics - IndexBox
Evolent Health (EVH) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
What are Evolent Health Inc. company’s key revenue driversCapitalize on emerging industry trends - Jammu Links News
What is the dividend policy of Evolent Health Inc. stockMassive stock growth - Jammu Links News
What is Evolent Health Inc. company’s growth strategyCapitalize on high-yield stock opportunities - Jammu Links News
Is Evolent Health Inc. a good long term investmentAchieve consistent double-digit returns - Jammu Links News
What drives Evolent Health Inc. stock priceBuild wealth faster with high-performing stocks - Jammu Links News
Should I hold or sell Evolent Health Inc. stock in 2025Discover high-impact stocks for your portfolio - Jammu Links News
What are analysts’ price targets for Evolent Health Inc. in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
Why is Evolent Health Inc. stock attracting strong analyst attentionCapitalize on fast-moving stock opportunities - Jammu Links News
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):